Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Tamir, Sagi ^a   Zuris, John A ^b   Agranat, Lily ^a   Lipper, Colin H ^b   Conlan, Andrea R ^b   Michaeli, Dorit ^a   Harir, Yael ^a   Paddock, Mark L ^b   Mittler, Ron ^c   Cabantchik, Zvi Ioav ^a   Jennings, Patricia A ^b   Nechushtai, Rachel ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CYSTEINE; HISTIDINE; HOMODIMER; IRON; IRON SULFUR PROTEIN; PIOGLITAZONE; PROTEIN NAF 1; RESVERATROL; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ARTICLE; CLUSTER ANALYSIS; DRUG PROTEIN BINDING; DRUG TARGETING; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON TRANSPORT; LONGEVITY; MITOCHONDRIAL MEMBRANE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; SPECTROPHOTOMETRY;

CELLS, CULTURED; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; IRON; MITOCHONDRIA; OXIDATION-REDUCTION; PROTEIN SUBUNITS; RIBONUCLEOPROTEINS; SMALL MOLECULE LIBRARIES; THIAZOLIDINEDIONES;

EID: 84878028290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061202     Document Type: Article

References (27)

1. Conlan AR, Axelrod HL, Cohen AE, Abresch EC, Zuris J, et al. (2009) Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram Syndrome 2. J Mol Biol 392: 143-153.
2. Paddock ML, Wiley SE, Axelrod HL, Cohen AE, Roy M, et al. (2007) MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc Natl Acad Sci U S A 104: 14342-14347.
3. Lin J, Zhou T, Ye K, Wang J (2007) Crystal structure of human mitoNEET reveals distinct groups of iron sulfur proteins. Proc Natl Acad Sci U S A 104: 14640-14645.
4. Hou X, Liu R, Ross S, Smart EJ, Zhu H, et al. (2007) Crystallographic studies of human MitoNEET. J Biol Chem 282: 33242-33246.
5. Boucquey M, De Plaen E, Locker M, Poliard A, Mouillet-Richard S, et al. (2006) Noxp20 and Noxp70, two new markers of early neuronal differentiation, detected in teratocarcinoma-derived neuroectodermic precursor cells. J Neurochem 99: 657-669.
6. Chang NC, Nguyen M, Bourdon J, Risse PA, Martin J, et al. (2012) Bcl-2-associated autophagy regulator Naf-1 required for maintenance of skeletal muscle. Hum Mol Genet 21: 2277-2287.
7. Chen YF, Kao CH, Chen YT, Wang CH, Wu CY, et al. (2009) Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev 23: 1183-1194.
8. Chen YF, Wu CY, Kirby R, Kao CH, Tsai TF (2010) A role for the CISD2 gene in lifespan control and human disease. Ann N Y Acad Sci 1201: 58-64.
9. Amr S, Heisey C, Zhang M, Xia XJ, Shows KH, et al. (2007) A Homozygous Mutation in a Novel Zinc-Finger Protein, ERIS, Is Responsible for Wolfram Syndrome 2. Am J Hum Genet 81: 673-683.
10. Chang NC, Nguyen M, Germain M, Shore GC (2010) Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J 29: 606-618.
11. Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, et al. (2004) Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe. Am J Physiol Endocrinol Metab 286: E252-260.
12. Wiley SE, Murphy AN, Ross SA, van der Geer P, Dixon JE (2007) MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc Natl Acad Sci U S A 104: 5318-5323.
13. Chen Z, Vigueira PA, Chambers KT, Hall AM, Mitra MS, et al. (2012) Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione. J Biol Chem 287: 23537-23548.
14. Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, et al. (2005) Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmacol 70: 177-188.
15. Gardner OS, Shiau CW, Chen CS, Graves LM (2005) Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 280: 10109-10118.
16. Hu Y, Liu HB, Simpson RW, Dear AE (2011) PPARgamma-independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells. J Endocrinol 208: R1-7.
17. Zuris JA, Harir Y, Conlan AR, Shvartsman M, Michaeli D, et al. (2011) Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc Natl Acad Sci U S A 108: 13047-13052.
18. Shvartsman M, Kikkeri R, Shanzer A, Cabantchik ZI (2007) Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications. Am J Physiol Cell Physiol 293: C1383-1394.
19. Fish A, Danieli T, Ohad I, Nechushtai R, Livnah O (2005) Structural Basis for the Thermostability of Ferredoxin from the Cyanobacterium Mastigocladus laminosus. J Mol Bio 350: 599-608.
20. Petrat F, Weisheit D, Lensen M, de Groot H, Sustmann R, et al. (2002) Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J 362: 137-147.
21. Glickstein H, El RB, Shvartsman M, Cabantchik ZI (2005) Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Blood 106: 3242-3250.
22. Wu G, Mansy SS, Wu SP, Surerus KK, Foster MW, et al. (2002) Characterization of an iron-sulfur cluster assembly protein (ISU1) from Schizosaccharomyces pombe. Biochemistry 41: 5024-5032.
23. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF (2003) The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66: 1499-1503.
24. Chakravarthi S, Jessop CE, Bulleid NJ (2006) The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Rep 7: 271-275.
25. Sohn YS, Breuer W, Munnich A, Cabantchik ZI (2008) Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111: 1690-1699.
26. Geldenhuys WJ, Funk MO, Awale PS, Lin L, Carroll RT (2011) A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET. Bioorg Med Chem Lett 21: 5498-5501.
27. Bieganski RM, Yarmush ML (2011) Novel ligands that target the mitochondrial membrane protein mitoNEET. J Mol Graph Model 29: 965-973.